title: Effects of Beta-Blocker Titration on Glucose Homeostasis in Heart Failure.
abstract: BACKGROUND: Abnormal glucose metabolism and insulin resistance have been associated with heart failure incidence, severity, and mortality. Metabolic parameters such as hepatic glucose production may be altered by beta-adrenoceptor antagonists in patients with heart failure. OBJECTIVE: This study evaluated the effects of metoprolol or carvedilol up-titration on fasting glucose, insulin resistance and beta(2)-mediated glucose production in patients with chronic heart failure. METHODS: This was a prospective, randomized, active comparator study in 15 patients with AHA/ACC Stage C systolic dysfunction HF stable on medical therapy. Participants were randomized to metoprolol 25mg daily or carvedilol 3.125mg twice daily. Metoprolol was titrated to a target of 200mg daily, and carvedilol was titrated to 25mg twice daily over 8weeks. Insulin resistance as assessed by the homeostatic model, and terbutaline-induced glucose production (AUC(0-180)), were assessed at baseline and at 4 subsequent beta-blocker titration visits over 8 weeks. RESULTS: In all 15 patients, terbutaline-induced glucose AUC(0-180) decreased (p=0.0006) as beta-blocker doses increased. A significant reduction in glucose AUC(0-180) compared to baseline was only noted in patients taking metoprolol at 100mg daily (-2424.6 [95% CI -372.6 to -4478.4] mg/dL*min) and 200mg daily (-2437.2 [95% CI -15.1 to -4604.4] mg/dL*min), and not observed in those taking carvedilol. After beta-blocker titration, fasting glucose concentrations for the metoprolol and carvedilol groups were 86.9 (95% CI 89.8-101.6) mg/dL and 95.7 (95% CI 89.8-101.6) mg/dL, respectively (p=0.0273), adjusted for baseline values. There was no significant difference between metoprolol and carvedilol on insulin resistance. CONCLUSION: Increasing doses of beta-blockers are associated with decreased in beta2-mediated glucose production in heart failure. Metoprolol, but not carvedilol, decreases hepatic glucose production at commonly used heart failure doses.
authors.affiliation: Assistant Professor, University of Wisconsin School of Pharmacy, Madison, WI.
authors.forename: Orly
authors.initials: O
authors.lastname: Vardeny
authors.forename: James
authors.initials: J
authors.lastname: Zebrack
authors.forename: Edward M
authors.initials: EM
authors.lastname: Gilbert
authors.forename: Kai I
authors.initials: KI
authors.lastname: Cheang
references.citation: Eur Heart J. 1994 Nov;15(11):1528-32
references.pmid: 7835369
references.citation: Cardiovasc Res. 2006 Jan;69(1):128-39
references.pmid: 16225854
references.citation: Heart. 2007 Aug;93(8):968-73
references.pmid: 17237130
references.citation: Lancet. 1995 Jul 8;346(8967):120-1
references.pmid: 7603193
references.citation: J Clin Endocrinol Metab. 1980 Apr;50(4):680-4
references.pmid: 6988452
references.citation: J Clin Invest. 1980 Mar;65(3):682-9
references.pmid: 6243675
references.citation: Circulation. 1999 Dec 7;100(23):2312-8
references.pmid: 10587334
references.citation: JAMA. 2005 Jul 20;294(3):334-41
references.pmid: 16030278
references.citation: Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4948-53
references.pmid: 15069206
references.citation: Eur Heart J. 2000 Aug;21(16):1368-75
references.pmid: 10952826
references.citation: J Clin Pharm Ther. 2003 Jun;28(3):179-86
references.pmid: 12795776
references.citation: J Hypertens. 1996 Apr;14(4):489-94
references.pmid: 8761899
references.citation: JAMA. 2004 Nov 10;292(18):2227-36
references.pmid: 15536109
references.citation: J Cardiovasc Pharmacol. 2000;35(7 Suppl 4):S9-14
references.pmid: 11346220
references.citation: N Engl J Med. 1991 Aug 1;325(5):293-302
references.pmid: 2057034
references.citation: N Engl J Med. 1987 Jun 4;316(23):1429-35
references.pmid: 2883575
references.citation: J Am Coll Cardiol. 2005 Sep 20;46(6):1019-26
references.pmid: 16168285
references.citation: Br J Pharmacol. 1999 Jul;127(5):1099-104
references.pmid: 10455254
references.citation: Diabetes Metab. 1997 Jun;23(3):213-8
references.pmid: 9233998
references.citation: J Clin Pharmacol. 1990 Feb;30(S2):S98-102
references.pmid: 2155948
references.citation: J Am Coll Cardiol. 2005 Dec 6;46(11):2054-60
references.pmid: 16325042
references.citation: J Am Coll Cardiol. 1997 Aug;30(2):527-32
references.pmid: 9247528